News

Martin Lehr 3/19/19 Martin Lehr 3/19/19

Context to Participate in Upcoming Investor Conferences in April

Context Therapeutics will present at the 18th Annual Needham Health Care Conference in New York City on Tuesday, April 9, 2019 at 2:30 p.m. ET.

Martin Lehr 2/27/19 Martin Lehr 2/27/19

Context Announces Presentation of New Antiprogestin at the 2019 AACR Annual Meeting

Context Therapeutics, a clinical-stage biotechnology company, today announced that new preclinical data on CTX-30916, a new PR antagonist, will be featured at the upcoming AACR Annual Meeting taking place in Atlanta, Georgia on April 1, 2019 .

Martin Lehr 12/18/18 Martin Lehr 12/18/18

Context Therapeutics Announces Key Additions to its Board of Directors

Context Therapeutics, a clinical-stage biopharmaceutical company dedicated to the treatment of hormone-responsive cancers, today announced two key additions to its board of directors.